199 related articles for article (PubMed ID: 23744100)
1. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
Kim SY; Han MY; Cha SH; Jeon YB
Pediatr Cardiol; 2013; 34(8):1837-43. PubMed ID: 23744100
[TBL] [Abstract][Full Text] [Related]
2. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
Pediatr Rheumatol Online J; 2019 Sep; 17(1):65. PubMed ID: 31533770
[TBL] [Abstract][Full Text] [Related]
3. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[TBL] [Abstract][Full Text] [Related]
7. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
Dahdah N; Siles A; Fournier A; Cousineau J; Delvin E; Saint-Cyr C; Spiegelblatt L; Bonny Y; Vartian M; Montigny M
Pediatr Cardiol; 2009 Aug; 30(6):810-7. PubMed ID: 19365652
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S
Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
11. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
Joung J; Oh JS; Yoon JM; Ko KO; Yoo GH; Cheon EJ
BMC Pediatr; 2022 Aug; 22(1):474. PubMed ID: 35931986
[TBL] [Abstract][Full Text] [Related]
12. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A; Pal P; Basu S
Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
[TBL] [Abstract][Full Text] [Related]
14. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
Iwashima S; Ishikawa T
World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
Yanagisawa D; Ayusawa M; Kato M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
Pediatr Int; 2016 Nov; 58(11):1105-1111. PubMed ID: 26991905
[TBL] [Abstract][Full Text] [Related]
18. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease.
Lee HY; Song MS
Korean J Pediatr; 2016 Dec; 59(12):477-482. PubMed ID: 28194213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
